News Category
Quantum BioPharma announced FDA approval of its IND application for Lucid-MS, a first-in-class neuroprotective candidate for multiple sclerosis, allow...
PX1 Research introduces US-manufactured sublingual peptide strips, including Retatrutide, offering a needle-free alternative for academic research wit...
PX1 Research's expansion of cGMP quality control and HPLC purity verification to all its US-manufactured research peptides provides academic and resea...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a mor...
New research from the University of Virginia suggests focused ultrasound may make brain tumor treatments more effective and less harmful, potentially ...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth and metastasis in TNBC models, supporting ...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a potential neuroprotective therapy for mult...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, led by TONMYA sales, marking a significant commercial milestone and providing cash run...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, driven by strong sales of its fibromyalgia drug TONMYA, marking a significant c...
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million, fueled by TONMYA sales, while the company progresses its clinical pipeline, signaling ...
A new narrative review in the World Journal of Pediatric Surgery provides a comprehensive, risk-based framework for diagnosing and treating neuroblast...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through key clinical, regulatory, and commercial stages, positionin...
Quantum BioPharma is advancing a two-pronged approach to neurological health, focusing on its MS therapy Lucid-MS and alcohol metabolism supplement un...
Quantum BioPharma is progressing its two-pronged approach to neurological health, advancing its MS therapy Lucid-MS and its alcohol metabolism supplem...
VERAXA Biotech's next-generation antibody platforms, including ADCs and T-cell engagers, position it to attract significant pharma investment and part...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer underscores the importance of proper food preparation and the need for...
Lantern Pharma's upcoming Q2 2026 webcast will detail financial results and progress on its AI-driven oncology platforms, underscoring the company's s...
VERAXA Biotech has advanced its VXA-222 bispecific ADC program beyond discovery and expanded its patent portfolio, strengthening its position in next-...
A new liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatment...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, supporting the scheduled Q4 20...
Researchers at Nagoya University discovered that the immune protein C3, when produced within tumors, can boost the effectiveness of immunotherapy, off...
NeuroThera Labs has initiated its Phase IIb clinical trial at Yale Child Study Center, advancing a novel cannabinoid-based treatment for Tourette Synd...
A new study finds that any level of physical activity is associated with reduced stroke and death risk in people with atrial fibrillation, emphasizing...
The US has recorded 2,371 measles cases this year, the highest in three decades, prompting health officials to intensify contact tracing and vaccinati...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital reaches halfway enrollment, showing promising preliminary data that cou...
Biotech Labz Supply Inc now offers 11 high-purity research peptides with batch-specific COA documentation, streamlining procurement for qualified labo...
Oncotelic Therapeutics will present at the OTCQB Virtual Investor Conference, showcasing significant advancements in its clinical trials and platform ...
Tonix Pharmaceuticals announced FDA feedback supporting an adaptive Phase 2 field study for its Lyme disease prevention candidate TNX-4800, marking a ...
Helus Pharma's appointment of Michael Halstead as CEO signals strategic preparation for commercialization as its lead candidate HLP003 advances throug...
Independent research suggests cross-reactive immune responses from licensed Ebola vaccines may extend to other ebolaviruses, reinforcing the strategic...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital reaches halfway enrollment, with preliminary data suggesting a more pre...
Center for Dental Implants expands to Aventura, offering both implant placement and restoration under one roof, reducing the need for multiple provide...
VERAXA Biotech has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer to lead the advancement of its proprieta...
A preclinical study suggests an experimental therapy containing vitamin B12 could halt the progression of glioblastoma multiforme, the deadliest brain...
VolitionRx announces increasing body of peer-reviewed studies supporting its Nu.Q H3.1 test as a biomarker for sepsis, showing ability to distinguish ...
Instinct Bio announced a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetic products in the U.S. and supply materials for ...
VERAXA Biotech announced an expansion of its intellectual property portfolio with new patent filings covering its BiTAC-TCE and BiTAC-ADC platforms, s...
VERAXA Biotech strengthens its scientific leadership with the appointment of Dr. Christoph Erkel as CSO, signaling a strategic push to advance its BiT...
A new study analyzing the 2025 AHA/ACC high blood pressure guideline found that 28% of U.S. adults with hypertension may be newly eligible for medicat...
Greenland Mines (NASDAQ: GRML) has been granted a Canadian patent for Klotho-based gene therapies targeting cognition, memory, and neurodegenerative d...
Quantum BioPharma's executive discusses the advancement of Lucid-MS for multiple sclerosis and the commercial potential of unbuzzd, highlighting the c...
Regentis Biomaterials is advancing its GelrinC cartilage regeneration platform through U.S. clinical enrollment and European commercialization, with s...
Greenland Mines Ltd. (NASDAQ: GRML) announced a Canadian patent for its Klotho-based gene therapy technology, covering treatments for Alzheimer's, Par...
A study aims to understand why some individuals with cancer risk factors develop the disease while others do not, focusing on autoantibodies and immun...
NanoViricides has submitted an application to begin a Phase II trial of its oral antiviral NV-387 for Bundibugyo ebolavirus in the DRC, where no appro...
Lantern Pharma announced EMA clearance for a Phase 1b/2 trial of LP-184 in advanced bladder cancer, advancing its AI-driven precision oncology strateg...
Physician reports from a large patient cohort at Mayo Clinic Florida indicate that NeuroOne's OneRF Brain Ablation System, used with its diagnostic SE...
GeoVax reports Q2 2026 financial results and progress on its GEO-MVA vaccine for mpox/smallpox, advancing toward a pivotal immunobridging study under ...
